YUSUKE AOKI, YUTARO KUBOTA, NORIYUKI MASAKI, KOYA OBARA, YASUNORI TOME, MICHAEL BOUVET, KOTARO NISHIDA, ROBERT M. HOFFMAN. Loss of Malignancy of Super-Methotrexate-resistant Osteosarcoma Cells Is Associated With an Increase of Methylated Histone Marks H3K9me3 and H3K27me3. Anticancer Research. 2024. 44. 10. 4213-4218
Hiroki Yabiku, Hideaki Nagamoto, Yasunori Tome, Kotaro Nishida, Tsukasa Kumai. Arthroscopic Resection of Symptomatic Ossicles of the Medial Malleolus Combined With Deltoid Ligament Repairs in Athletes: A Report of Three Cases. Cureus. 2024. 16. 7. e64521
KOHEI MIZUTA, RYOSUKE MORI, QINGHONG HAN, SEI MORINAGA, MOTOKAZU SATO, BYUNG MO KANG, MICHAEL BOUVET, YASUNORI TOME, KOTARO NISHIDA, ROBERT M. HOFFMAN. The Combination of Methionine Restriction and Docetaxel Synergistically Arrests Androgen-independent Prostate Cancer But Not Normal Cells. Cancer Diagnosis & Prognosis. 2024. 4. 4. 402-407
KOHEI MIZUTA, BYUNG MO KANG, QINGHONG HAN, YUTARO KUBOTA, SEI MORINAGA, MOTOKAZU SATO, MICHAEL BOUVET, YASUNORI TOME, KOTARO NISHIDA, ROBERT M. HOFFMAN. Expression of PD-L1 Is Increased by Methionine Restriction Using Recombinant Methioninase in Human Colorectal Cancer Cells. Cancer Genomics & Proteomics. 2024. 21. 4. 395-398
YUSUKE AOKI, YUTARO KUBOTA, NORIYUKI MASAKI, KOYA OBARA, YASUNORI TOME, MICHAEL BOUVET, KOTARO NISHIDA, ROBERT M. HOFFMAN. Reduced Malignancy of Super Methotrexate-resistant Osteosarcoma Cells With Dihydrofolate Reductase Amplification Despite Paradoxical Gain of Oncogenic PI3K/AKT/mTOR and c-MYC expression. Anticancer Research. 2024. 44. 7. 2787-2792